Vidal says OpenSky abused IPR process in billion-dollar case

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Vidal says OpenSky abused IPR process in billion-dollar case

Kathi Vidal

In a director review decision, the USPTO chief said OpenSky’s attempt to extract payment from VLSI and Intel and undermine proceedings was a violation

USPTO director Kathi Vidal slapped down patent challenger OpenSky today, October 4, for abusing the inter partes review process at the Patent Trial and Appeal Board in a case worth more than $2 billion.

In her director review decision, Vidal said OpenSky violated the process by attempting to extract payment from patent owner VLSI and joint petitioner Intel and offering to undermine proceedings in exchange.

“Taken together, the behaviour warrants sanctions to the fullest extent of my power,” Vidal wrote. “Not only are such sanctions proportional to the conduct here, but they are necessary to deter such conduct by OpenSky or others in the future.”

She sanctioned the patent challenger by blocking it from actively participating in the IPR and temporarily elevating Intel to the position of lead petitioner in the OpenSky v VLSI dispute.

Vidal also demanded that OpenSky make a case for why it shouldn’t be ordered to pay compensatory damages to VLSI, including attorney fees.

The director didn’t dismiss the proceeding but ordered, in an effort to balance the competing interests at issue, that the case be remanded to the PTAB to determine whether the petition presented a compelling and meritorious challenge.

The board should make the decision within the next two weeks, she said, based only on the record before the PTAB prior to institution.

Vidal accepted the case for director review after VLSI, a non-practising entity owned by investment funds managed by the Fortress Investment Group, alerted the PTAB to an email it received from OpenSky last March.

The email suggested that the two “work together to secure dismissal or defeat” and that OpenSky might agree not to pay its expert to appear at a deposition as part of the deal, according to VLSI.

OpenSky, which was incorporated in April 2021, challenged VLSI’s patent at the PTAB shortly after the NPE won a $2.18 billion jury verdict against Intel at the District Court for the Western District of Texas in March 2021.

The PTAB instituted the challenge in December 2021, having previously denied a similar petition brought by Intel on discretionary grounds.

more from across site and SHARED ros bottom lb

More from across our site

Erise IP has added a seven-practitioner trademark team from Hovey Williams, signalling its intention to help clients at all stages of development
News of prison sentences for ex-Samsung executives for trade secrets violation and an opposition filed by Taylor Swift were also among the top talking points
A multijurisdictional claim filed by InterDigital and a new spin-off firm in Germany were also among the top talking points
Duarte Lima, MD of Spruson & Ferguson’s Asia practice, says practitioners must adapt to process changes within IP systems, as well as be mindful of the implications of tech on their practices
Practitioners say the UK Supreme Court’s decision could boost the attractiveness of the UK for AI companies
New awards, including US ‘Firm of the Year’ and Latin America ‘Firm to Watch’, are among more than 90 prizes that will recognise firms and practitioners
DWF helped client Dairy UK secure a major victory at the UK Supreme Court
Hepworth Browne led Emotional Perception AI to victory at the UK Supreme Court, which rejected a previous appellate decision that said an AI network was not patentable
James Hill, general counsel at Norwich City FC, reveals how he balances fan engagement with brand enforcement, and when he calls on IP firms for advice
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Gift this article